Nautilus Biotechnolgy's total assets for Q1 2025 were $227.69M, a decrease of -6.20% from the previous quarter. NAUT total liabilities were $33.26M for the fiscal quarter, a -2.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.